JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Cervical crypt involvement by intraepithelial neoplasia.

Knowledge of the frequency and extent of crypt involvement by cervical intraepithelial neoplasia (CIN) is important when treatment by electrodiathermy, cryosurgery, or the laser is considered. Three hundred forty-three therapeutic cone biopsies carried out at The Samaritan Hospital for Women, London, have been reviewed histologically. Measurements were made of the deepest crypt in each specimen and of the deepest crypt that contained CIN. The mean depth of involved crypts was 1.24 mm, and the mean depth of uninvolved crypts was 3.38 mm. Thus, destruction of tissue to a depth of 2.92 mm (mean + 1.96 SD) would eradicate all involved crypts in 95% of patients, whereas destruction to a depth of 3.80 mm would eradicate 99.7% (mean + 3 SD). There is also an increase in the depth of crypt involvement with increasing age, but the differences between the age groups are not statistically significant.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app